A.R.T. Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,600	Closed	-$657K	–	1336
2017 Q3	$657K	Sell	5,600 -44,900	-89%	-$3.83M	0.03%	718
2017 Q2	$4.03M	Buy	50,500 +42,300	+516%	+$2.7M	0.21%	101
2017 Q1	$420K	Sell	8,200 -34,500	-81%	-$1.59M	0.02%	870
2016 Q4	$1.6M	Buy	+42,700	New	+$1.79M	0.1%	337
2016 Q3	–	Sell	-29,084	Closed	-$1.61M	–	644
2016 Q2	$1.61M	Sell	29,084 -3,900	-12%	-$246K	0.08%	379
2016 Q1	$2.07M	Buy	+32,984	New	+$2.19M	0.09%	322
2015 Q4	–	Sell	-10,891	Closed	-$875K	–	1442
2015 Q3	$875K	Sell	10,891 -10,113	-48%	-$1.12M	0.03%	670
2015 Q2	$2.52M	Sell	21,004 -11,294	-35%	-$1.35M	0.08%	367
2015 Q1	$3.37M	Buy	32,298 +21,946	+212%	+$2.22M	0.12%	239
2014 Q4	$1M	Buy	+10,352	New	+$959K	0.04%	643
2014 Q2	–	Sell	-11,349	Closed	-$761K	–	1287
2014 Q1	$761K	Buy	+11,349	New	+$879K	0.04%	595
2013 Q4	–	Sell	-121,215	Closed	-$7.76M	–	1252
2013 Q3	$7.76M	Buy	121,215 +9,755	+9%	+$486K	0.42%	20
2013 Q2	$3.46M	Buy	+111,460	New	+$2.97M	0.11%	254